@article{fecc825f6b3e422ca19cf25e6932c740,
title = "Dual Antiplatelet Therapy Following PCI for NSTEMI: An Obvious Choice or a Calculated Decision?",
keywords = "dual antiplatelet therapy, non-ST-segment elevation acute coronary syndrome, percutaneous coronary intervention, prasugrel, ticagrelor",
author = "Serge Korjian and George Dangas and Gibson, {C. Michael}",
note = "Funding Information: Dr. Gibson has received research grants and consulting funds from Eli Lilly and AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",
year = "2020",
month = nov,
day = "24",
doi = "10.1016/j.jacc.2020.10.012",
language = "English",
volume = "76",
pages = "2447--2449",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "21",
}